Ancora Advisors’s Hepion Pharmaceuticals HEPA Stock Holding History

Ancora Advisors’s Portfolio HEPA Stock Details HEPA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	1	–	–	﹤0.01%	2165
2026 Q1	$0	Hold	1	–	–	﹤0.01%	2465
2025 Q4	$0	Hold	1	–	–	﹤0.01%	2468
2025 Q3	$0	Buy	+1	New	–	﹤0.01%	1998

Ancora Advisors's HEPA Position: Q2 2026 in Review

Ancora Advisors held its Hepion Pharmaceuticals (HEPA) position steady in Q2 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2165.

Ancora Advisors first reported a position in HEPA in Q3 2025 and has held it in 4 quarters since. 1 fund tracked by Wall St. Rank holds HEPA as of Q2 2026.

Ancora Advisors held 1 share of Hepion Pharmaceuticals worth $0 as of Q2 2026.
Ancora Advisors left its Hepion Pharmaceuticals share count unchanged in Q2 2026.
Hepion Pharmaceuticals made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #2165 holding.
Ancora Advisors first reported a position in Hepion Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
1 fund tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.